PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.45%
Negative revenue growth while 2127.T stands at 4.65%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.98%
Negative gross profit growth while 2127.T is at 6.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.81%
Negative EBIT growth while 2127.T is at 4.36%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-20.34%
Negative operating income growth while 2127.T is at 6.38%. Joel Greenblatt would press for urgent turnaround measures.
-18.30%
Negative net income growth while 2127.T stands at 1.07%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-18.29%
Negative EPS growth while 2127.T is at 1.05%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.29%
Negative diluted EPS growth while 2127.T is at 1.05%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.35%
10Y revenue/share CAGR under 50% of 2127.T's 63.02%. Michael Burry would suspect a lasting competitive disadvantage.
4.35%
5Y revenue/share CAGR under 50% of 2127.T's 63.02%. Michael Burry would suspect a significant competitive gap or product weakness.
-22.63%
Negative 3Y CAGR while 2127.T stands at 39.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
84.25%
Net income/share CAGR at 75-90% of 2127.T's 100.30%. Bill Ackman would press for strategic moves to boost long-term earnings.
84.25%
5Y net income/share CAGR at 75-90% of 2127.T's 100.30%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
3.41%
Below 50% of 2127.T's 42.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
37.80%
Equity/share CAGR of 37.80% while 2127.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
37.80%
Equity/share CAGR of 37.80% while 2127.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-6.14%
Negative 3Y equity/share growth while 2127.T is at 72.40%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.53%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
11.89%
Inventory shrinking or stable vs. 2127.T's 70.23%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.36%
Asset growth at 50-75% of 2127.T's 11.18%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.37%
50-75% of 2127.T's 7.52%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
307.59%
Debt growth of 307.59% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
2.63%
SG&A declining or stable vs. 2127.T's 5.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.